论文信息 - A phase 2a proof of concept clinical trial to evaluate ZPL-3893787 (ZPL-389) a potent, oral histamine H4, receptor antagonist for the treatment of moderate to severe atopic dermatitis (AD) in adults - 字舞流文

A phase 2a proof of concept clinical trial to evaluate ZPL-3893787 (ZPL-389) a potent, oral histamine H4, receptor antagonist for the treatment of moderate to severe atopic dermatitis (AD) in adults

A. Nikkels | M. Yeadon | G. Layton | A. Gawlik | P. Staubach | T. Werfel | L. Purkins | R. Sarmiento | A. Tsianakas | L. Whitlock | K. Breuer | M. Morren | Wai L Liu | V. Lynch | A. Asher | K. Buczyłko | A. Płoszczuk | B. Majorek-Olechowska | T. Hofman | B. Gupta | B. Cimoszko